NRG Oncology NCORP Research Base
NRG肿瘤学NCORP研究基地
基本信息
- 批准号:10247230
- 负责人:
- 金额:$ 14.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdjuvantAdvocateAffectAftercareAreaBehavior TherapyCancer CenterCancer ControlCancer Control ResearchCaringClinicalClinical Research AssociateClinical TrialsClinical Trials DesignCollaborationsCollectionCommunitiesCommunity Clinical Oncology ProgramCommunity PhysicianConcept ReviewCorrelative StudyCredentialingDataData AnalysesData CollectionDevelopmentDiseaseElderlyEnsureEvidence based interventionExposure toFamilyFundingGenderGeneticGoalsGrantGynecologic Oncology GroupHealth Services AccessibilityHospice CareImageImmunotherapyInformation TechnologyInfrastructureInterventionIntervention TrialLeadershipLocalized Malignant NeoplasmLymphedemaMalignant NeoplasmsMentorshipMethodologyMinorityModalityModificationMolecularMonitorNational Cancer InstituteNational Clinical Trials NetworkNational Surgical Adjuvant Breast and Bowel ProjectNeurocognitiveOncologyOutcomeOutcomes ResearchPalliative CarePatient Outcomes AssessmentsPatient-Focused OutcomesPatientsPhasePrimary Health CarePrincipal InvestigatorQuality ControlQuality of lifeRadiation OncologyRadiation Therapy Oncology GroupRadiation therapyRandomizedReportingResearchResearch PersonnelResourcesRisk ReductionRural PopulationSecuritySeriesSex FunctioningSiteSolid NeoplasmSouthwest Oncology GroupSurvivorsSymptomsTestingTherapeutic Clinical TrialTherapeutic TrialsTimeToxic effectTrainingTraining ActivityTraining ProgramsTraining and EducationTranslational ResearchTreatment-Related CancerWomanWomen&aposs HealthWorkbasebiomarker evaluationcancer carecancer diagnosiscancer health disparitycancer preventioncancer riskcancer therapycare deliverycare outcomesclinical imagingclinical practicecommunity centercost effectivenessdata integritydata managementdesigndisorder riskeffectiveness testingethnic minority populationevidence baseexperiencehealth disparityimprovedinnovationmembermultidisciplinarynext generationprogramsquality assuranceracial minorityscreeningsurvivorshipsymptom managementtherapeutic evaluationtherapy designtreatment trialtrial designunderserved minority
项目摘要
The objective of this proposal is to establish and maintain the NCORP (National Community
Oncology Research Program) for the NRG Oncology research base. The NRG NCORP is the
result of aligning the legacy CCOPs (Community Clinical Oncology Programs) from three NCI
Cancer Cooperative Groups: NSABP, RTOG and GOG. These groups together have over
almost 100 years of combined experience serving as CCOP Research Bases. NRG NCORP,
comprised of a multi-disciplinary team of investigators and patient advocates, is poised to carry
out the objectives of: 1) designing and conducting cancer prevention, control and screening
clinical trials; 2) designing and embedding patient reported outcomes in both primary NCOPR
trials as well as NRG therapeutic trials 3) designing and conducting cancer care delivery
research; 4) enhancing community access to treatment and imaging trials conducted under the
National Clinical Trials Network (NCTN) and 5) conducting primary intervention trials and
integrating health disparity research questions into cancer care delivery research and treatment
trials. To allow NRG NCORP to meet these goals, the group will: participate fully in NRG
Oncology leadership and will determine the scientific direction and prioritization of the NRG
NCORP activities and resources and oversee the translational research, clinical trial activities,
and correlative studies related to the aims of NRG NCORP. With the NRG Statistical and Data
Management Center (SDMC), this team will provide efficient, methodologically up-to-date trial
design with a focus on NCORP specific needs such as patient-reported repeated longitudinal
assessments and cluster-randomized designs. NRG NCORP will provide study monitoring,
reporting, and analysis; build an infrastructure to support our cancer care delivery research
agenda; provide comprehensive data management quality control and quality assurance
programs to ensure high data integrity and timely data for analysis; leverage cutting edge
information technology emphasizing security, timeliness, and efficiency of data collection and
management; providing RT credentialing and quality assurance; and provide education and
training for institutional Clinical Research Associates, Study Chairs, local Principal Investigators
and others involved in the NRG NCORP research agenda. Further, to accomplish these aims
NRG NCORP will engage fully with NCI-designated NCORP community physicians and patient
advocates as well as the NCI and other NCI-sponsored entities (cooperative groups, cancer
centers, SPOREs) to collaborate across the NCTN to improve cancer prevention and control,
cancer care and outcomes, and quality of life for patients affected by cancer.
本提案的目的是建立和维护NCORP(国家社区
肿瘤学研究计划)为NRG肿瘤学研究基地。NRG NCORP是
将三个NCI的传统CCOP(社区临床肿瘤学计划)
癌症合作组织:NSABP、RTOG和GOG。这些团体加起来有超过
近100年的综合经验,作为CCOP研究基地。NRG NCORP,
由多学科的研究人员和患者倡导者组成的团队,
制定了以下目标:1)设计和开展癌症预防、控制和筛查
临床试验; 2)设计并嵌入患者报告的主要NCOPR结局
试验以及NRG治疗试验3)设计和实施癌症护理服务
研究; 4)加强社区获得治疗和成像试验根据
国家临床试验网络(NCTN)和5)进行初级干预试验,
将健康差异研究问题纳入癌症护理提供研究和治疗
审判为了使NRG NCORP能够实现这些目标,该集团将:
肿瘤学领导层,并将确定NRG的科学方向和优先顺序
NCORP的活动和资源,并监督转化研究,临床试验活动,
以及与NRG NCORP目标相关的相关研究。NRG统计和数据
管理中心(SDMC),该团队将提供高效,方法学上最新的试验
设计重点关注NCORP特定需求,例如患者报告的重复纵向
评估和随机分组设计。NRG NCORP将提供研究监查,
报告和分析;建立基础设施,以支持我们的癌症护理提供研究
提供全面的数据管理、质量控制和质量保证
确保高数据完整性和及时分析数据的计划;利用尖端技术
信息技术强调数据收集的安全性、及时性和效率,
管理;提供RT认证和质量保证;并提供教育和
机构临床研究助理、研究主席、当地主要研究者的培训
和其他参与NRG NCORP研究议程的人。此外,为了实现这些目标,
NRG NCORP将与NCI指定的NCORP社区医生和患者充分接触
倡导者以及NCI和其他NCI赞助的实体(合作团体,癌症
中心,SPORE)在NCTN合作,以改善癌症预防和控制,
癌症护理和结果,以及癌症患者的生活质量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Deborah Watkins Bruner其他文献
Automated segmented field selection for IMRT using utility based decision theory
- DOI:
10.1016/s0360-3016(98)80264-2 - 发表时间:
1998-01-01 - 期刊:
- 影响因子:
- 作者:
Gregory E. Desobry;Deborah Watkins Bruner;Benjamin Movsas;Timothy E. Schultheiss - 通讯作者:
Timothy E. Schultheiss
When Patience is a Failing: The Case for Patient Reported Outcomes Adoption
- DOI:
10.1016/j.ijrobp.2023.01.041 - 发表时间:
2023-07-15 - 期刊:
- 影响因子:
- 作者:
Deborah Watkins Bruner - 通讯作者:
Deborah Watkins Bruner
Assessing women's sexuality after cancer therapy: checking assumptions with the focus group technique.
评估癌症治疗后女性的性行为:用焦点小组技术检查假设。
- DOI:
10.1097/00002820-199912000-00007 - 发表时间:
1999 - 期刊:
- 影响因子:2.6
- 作者:
Deborah Watkins Bruner;Coleen P. Boyd - 通讯作者:
Coleen P. Boyd
The Influence of Gender, Race, and Marital Status on Survival in Lung Cancer Patients: Meta-analysis of Radiation Therapy Oncology Group (RTOG) Trials
性别、种族和婚姻状况对肺癌患者生存的影响:放射治疗肿瘤学组 (RTOG) 试验的荟萃分析
- DOI:
10.1016/j.ijrobp.2009.07.381 - 发表时间:
2009 - 期刊:
- 影响因子:7
- 作者:
Deborah Watkins Bruner;Kwanghyuk Bae;F. Siddiqui;C. Langer;J. Coyne;Victoria Gamerman;R. Komaki;H. Choy;W. Curran;B. Movsas - 通讯作者:
B. Movsas
Associations among HPV persistence, the vaginal microbiome, and cervical cancer recurrence
- DOI:
10.1186/s12967-025-06811-w - 发表时间:
2025-08-01 - 期刊:
- 影响因子:7.500
- 作者:
Despina Tsementzi;Rebecca Meador;Tony Eng;Joseph Shelton;Isabelle Scott;Konstantinos T. Konstantinidis;Susan Modesitt;Deborah Watkins Bruner - 通讯作者:
Deborah Watkins Bruner
Deborah Watkins Bruner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Deborah Watkins Bruner', 18)}}的其他基金
Research Training in Women's Health and Intersectionality Using Data Science and Health Information Technology (WISDOM)
利用数据科学和健康信息技术 (WISDOM) 进行妇女健康和交叉性研究培训
- 批准号:
10628160 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Randomized Feasibility Study of Dilator Use and an Educational Program to Increas
扩张器使用的随机可行性研究和增加教育计划
- 批准号:
7706328 - 财政年份:2009
- 资助金额:
$ 14.96万 - 项目类别:
Randomized Feasibility Study of Dilator Use and an Educational Program to Increas
扩张器使用的随机可行性研究和增加教育计划
- 批准号:
8367931 - 财政年份:2009
- 资助金额:
$ 14.96万 - 项目类别:
相似海外基金
Metachronous synergistic effects of preoperative viral therapy and postoperative adjuvant immunotherapy via long-term antitumor immunity
术前病毒治疗和术后辅助免疫治疗通过长期抗肿瘤免疫产生异时协同效应
- 批准号:
23K08213 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Improving the therapeutic immunity of cancer vaccine with multi-adjuvant polymeric nanoparticles
多佐剂聚合物纳米粒子提高癌症疫苗的治疗免疫力
- 批准号:
2881726 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Studentship
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Evaluation of the Sensitivity to Endocrine Therapy (SET ER/PR) Assay to predict benefit from extended duration of adjuvant endocrine therapy in the NSABP B-42 trial
NSABP B-42 试验中内分泌治疗敏感性 (SET ER/PR) 测定的评估,用于预测延长辅助内分泌治疗持续时间的益处
- 批准号:
10722146 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
流感疫苗类 AS01 合成佐剂系统 SAS 的开发
- 批准号:
10935776 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
DEVELOPMENT OF SMALL-MOLECULE DUAL ADJUVANT SYSTEM FOR INFLUENZA VIRUS VACCINE
流感病毒疫苗小分子双佐剂体系的研制
- 批准号:
10935796 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
A GLYCOLIPID ADJUVANT 7DW8-5 FOR MALARIA VACCINES
用于疟疾疫苗的糖脂佐剂 7DW8-5
- 批准号:
10935775 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Adjuvant strategies for universal and multiseasonal influenza vaccine candidates in the context of pre-existing immunity
在已有免疫力的情况下通用和多季节流感候选疫苗的辅助策略
- 批准号:
10649041 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:
Adjuvant Photodynamic Therapy to Reduce Bacterial Bioburden in High-Energy Contaminated Open Fractures
辅助光动力疗法可减少高能污染开放性骨折中的细菌生物负载
- 批准号:
10735964 - 财政年份:2023
- 资助金额:
$ 14.96万 - 项目类别:














{{item.name}}会员




